RET and cancer: Since oncogenic Ret mutations promote cancer growth in part by activation of the TORC1 pathway [36],[37], our findings suggest that aberrant Ret signaling may suppress autophagy during cancerous growth, potentially providing an advantageous mechanism or driving force for the growth of Ret-expressing tumors.